IRadimed Corporation

NASDAQ:IRMD

Medical - Devices

Healthcare
$82.31 +0.73%

+$0.67 today

Market cap
$1.05B
Beta
0.92
P/E (TTM)
49.7
EPS (TTM)
$1.85
Dividend yield
1.35%
52W Low $55.11High $107.90

Volume 0.08M

Average 0.12M

IRMD Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

IRadimed CorporationNASDAQ: IRMD

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 12.78M shares rose 0.5% year over year, in line with the +0.4% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.4% from the prior quarter. Over 3 fiscal years it compounded at +0.4% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +0.5% holds above the trailing-twelve-month pace of +0.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
12.78M+0.4% QoQ
Last fiscal yearDec 2025
12.72M+0.4% YoY
LTMMar 2026
12.74M+0.4% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.5%——
1 year+0.4%——
3-year CAGR+0.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
12.72M USD
Year-over-year change
+0.4%
4-year CAGR
+0.8%

Weighted Avg Shares vs competitors

How IRMD compares with its peers on the latest reported figures

  • IRMD's LTM Mar 2026 weighted avg shares of 12.74M shares is the lowest of the 11 companies compared; the peer median is 106.06M shares.
  • Its year-over-year change of +0.4% is the 8th highest of 11, against a peer median of +0.8%.
  • Over three fiscal years its annual growth of +0.4% compares with a peer median of +0.8%.
IRMD Competitors Peer median
Weighted Avg Shares for IRMD and competitors
Company Period LTM YoY 3-year CAGR
OPKOPKO Health, Inc.LTM Mar 2026772.39M +8.0%+1.5%
CRONCronos Group Inc.LTM Mar 2026385.31M +0.8%+0.7%
GDRXGoodRx Holdings, Inc.LTM Mar 2026346.3M -8.7%-4.8%
MDXGMiMedx Group, Inc.LTM Mar 2026148.01M +0.6%+9.4%
AHCOAdaptHealth Corp.LTM Apr 2026135.39M +0.9%+0.2%
IARTIntegra LifeSciences Holdings CorporationLTM Mar 202676.73M -0.1%-2.6%
TNDMTandem Diabetes Care, Inc.LTM Mar 202667.78M +3.1%+1.6%
INMDInMode Ltd.LTM Mar 202663.32M -16.0%-7.8%
AXGNAxoGen, Inc.LTM Sep 202651.75M +14.0%+3.0%
CTEVClaritev CorporationLTM Mar 202616.52M +2.1%+1.0%
IRMDIRadimed CorporationLTM Mar 202612.74M +0.4%+0.4%
Peer median (excluding IRMD) 106.06M+0.8%+0.8%

Competitors are the stored peer set for IRMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue41.81M53.3M65.56M73.24M83.81M
Cost of Revenue9.76M12.02M15.4M16.89M19.49M
Gross Profit32.05M41.28M50.16M56.35M64.32M
Gross Margin76.6%77.4%76.5%76.9%76.7%
Research & Development1.91M2.28M2.86M2.83M2.98M
Selling, General & Admin20.33M23.38M27.26M31.55M35.2M
Operating Expenses22.23M25.65M30.12M34.39M38.18M
Depreciation & Amortization1.41M670.67K765.18K817.66K2.38M
EBITDA11.24M16.85M22.5M25.09M30.74M
EBITDA Margin26.9%31.6%34.3%34.3%36.7%
Operating Income9.82M15.63M20.04M21.96M26.15M
Operating Margin23.5%29.3%30.6%30.0%31.2%
Interest Income34.81K581.85K1.86M2.19M0
Interest Expense00000
Other Income / Expenses18.61K553.1K1.7M2.31M2.21M
Income Before Tax9.84M16.18M21.74M24.28M28.36M
Pre-Tax Margin23.5%30.4%33.2%33.1%33.8%
Income Tax Expense510.82K3.35M4.55M5.04M5.88M
Net Income9.33M12.83M17.19M19.23M22.48M
Net Margin22.3%24.1%26.2%26.3%26.8%
EPS (Basic)0.761.021.361.521.77
EPS (Diluted)0.741.021.351.501.75
Weighted Avg Shares12.35M12.56M12.6M12.67M12.72M
Weighted Avg Shares (Diluted)12.59M12.64M12.72M12.78M12.85M

IRadimed Corporation

NASDAQ:IRMD

Intrinsic Alpha fair value

Locked

Current Price

$82.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.